Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. interventional cardiology
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Videos

Refine by
Date

  • Older

Interventional Cardiology Articles & Analysis: Older

26 news found

An Easy, Predictable, and Simpler Way to Embolize Tumors

An Easy, Predictable, and Simpler Way to Embolize Tumors

The products of four hydrogel companies Sawhney founded with his partner Fred Khosravi (within their accelerator Incept LLC), have treated more than five million patients across the ophthalmic, surgical, interventional cardiology, and prostate cancer specialties. Sawhney founded Confluent Surgical in 1998, which, after proving out a hydrogel platform for ...

ByInstylla, Inc.


Osso VR and American College of Cardiology to Develop Immersive Training for Cardiovascular Professionals

Osso VR and American College of Cardiology to Develop Immersive Training for Cardiovascular Professionals

Osso VR, now the largest and fastest-growing virtual reality (VR) company in healthcare, and the American College of Cardiology (ACC), a global nonprofit dedicated to transforming cardiovascular care, today announced a new collaboration to develop an immersive, VR-enabled training program for cardiovascular professionals. ...

ByOsso VR, Inc.


Belgian scale-up Oncomfort raises €10 million in Series A funding co-led by Debiopharm and Crédit Mutuel Innovation

Belgian scale-up Oncomfort raises €10 million in Series A funding co-led by Debiopharm and Crédit Mutuel Innovation

Since the launch of the Sedakit™ for Digital Sedation in Benelux and France in June 2019, over 30,000 patients have been treated and have had their pain and anxiety relieved before, during, and after interventions in many clinical fields such as anesthesia, oncology, interventional radiology and cardiology, as well as pediatrics. ...

ByOncomfort


Arterius Welcomes New Clinical Advisers

Arterius Welcomes New Clinical Advisers

Serruys is is a professor of Interventional Cardiology at the Interuniversity Cardiological Institute of the Netherlands (1988-1998), and Erasmus MC. ...

ByArterius Limited


Robocath achieves positive results in R-Evolution multicenter European clinical study on robotic coronary angioplasty

Robocath achieves positive results in R-Evolution multicenter European clinical study on robotic coronary angioplasty

It is now the only viable and long-term answer to procedures becoming increasingly long and complex and requiring high precision, expertise and experience in interventional cardiology. While it is revolutionary, the system uses the same devices as those currently used and is compatible with all imaging systems, which should make uptake easy among all ...

ByRobocath


BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Cell Therapy Heart Failure Study as Designed

BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Cell Therapy Heart Failure Study as Designed

The DSMB consists of two world renowned cardiologists with experience in heart failure and interventional cardiology, as well as a world-renowned biostatistician with considerable experience evaluating trial data for chronic diseases, including heart failure. ...

ByBiocardia, Inc.


Robocath concludes first European clinical study to demonstrate safety and efficacy of robotic coronary angioplasty performed with R-One

Robocath concludes first European clinical study to demonstrate safety and efficacy of robotic coronary angioplasty performed with R-One

Van Der Ent; and the National Interventional Cardiac Surgery Institute in Luxembourg with Dr Pereira and Dr Muller. ...

ByRobocath


Robocath successfully completes first robotic coronary angioplasty with R-One in China

Robocath successfully completes first robotic coronary angioplasty with R-One in China

The procedure took place at the 301 Hospital in Beijing on November 24; performed by Dr. Yundai Chen, a renowned interventional cardiologist and author of several scientific publications. This robotic assisted procedure is the first intervention within a clinical study carried out by CathBot; a joint venture between Robocath and MedBot (the robot-focused ...

ByRobocath


InspireMD Announces Publication of 12-Month Results of CGuard™ EPS SIBERIA Trial in Journals of the American College of Cardiology: Cardiovascular Interventions

InspireMD Announces Publication of 12-Month Results of CGuard™ EPS SIBERIA Trial in Journals of the American College of Cardiology: Cardiovascular Interventions

InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced that results from the investigator-initiated SIBERIA randomized clinical trial of CGuard EPS, that evaluated the peri-procedural and 30-day silent brain infarcts associated with the use of its ...

ByInspireMD Inc.


DurAVR accepted into TCT innovation session

DurAVR accepted into TCT innovation session

The TCT conference, running from November 4 to 6, is the largest and most prestigious Interventional cardiology meeting held each year and will return to an “in-person” meeting format. ...

ByAnteris Technologies Limited


CARMAT appoints Ivo Simundic as Sales director for the DACH region to support the deployment of the Aeson artificial heart in Germany, Austria and Switzerland

CARMAT appoints Ivo Simundic as Sales director for the DACH region to support the deployment of the Aeson artificial heart in Germany, Austria and Switzerland

In 2011, Ivo Simundic joined Xenios AG where he co-invented, co-developed and obtained the CE marking for the i-cor® project – the first synchronized pulsatile cardiac assist for interventional cardiology to treat cardiogenic shock and to protect cath-lab interventions. Following the acquisition of Xenios AG by Fresenius Medical Care in ...

ByCarmat


BIOMODEX Technology Enables New Milestone in Interventional Cardiology

BIOMODEX Technology Enables New Milestone in Interventional Cardiology

BIOMODEX, the leader in bio-realistic haptic simulators for patient-specific rehearsal and physician training, today announced that its LAACS (Left Atrial Appendage Closure System) solution was used to perform a simulation ahead of a live case to be presented at the TVT Structural Heart Summit in Miami, FL. Physicians at the Montreal Heart Institute in Montreal, Quebec recently rehearsed the ...

ByBIOMODEX


First Five Patients Successfully Treated with atHeart Medical’s Novel reSept Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial

First Five Patients Successfully Treated with atHeart Medical’s Novel reSept Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial

” Current ASD occluders have metallic frames that can place patients at risk for complications and prohibit future transseptal interventions. Initial clinical experience demonstrates effective closure of the ASDs treated with the company’s device.1 “The metal-free frame of the reSept ASD Occluder provides a low-profile that over time is replaced by the ...

ByatHeart Medical


The long-term solution for stressed New York hearts

The long-term solution for stressed New York hearts

Avicenna Cardiology is located on Park Avenue in Manhattan, New York. The clinic is led by Dr. ...

ByCoala Life Inc.


Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences

Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences

Results were presented at the American College of Cardiology Scientific Session (ACC.21) and at the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EuroPCR 2021) by Colin Barker, MD, Director of Interventional Cardiology at Vanderbilt University, Nashville, TN and Jacob Kriegel, MD, Chief ...

ByAlleviant Medical, Inc.


Robocath successfully completes first robotic coronary angioplasties in Belgium

Robocath successfully completes first robotic coronary angioplasties in Belgium

The study aims to demonstrate the many benefits for interventional cardiologists of robotic use within daily practice. Prof. Stefan Verheye, Interventional Cardiologist at ZNA Middelheim, Antwerp, member of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and author of over 170 peer-reviewed papers (mainly ...

ByRobocath


Newly Formed Company, atHeart Medical, Aims to Evolve Septal Closure with the reSept ASD Occlude

Newly Formed Company, atHeart Medical, Aims to Evolve Septal Closure with the reSept ASD Occlude

The novel implant is poised to overcome the limitations of current occluders, as it aims to reduce the risk of complications associated with the long-term presence of metal in the heart and to preserve future treatment options requiring transseptal intervention. Initial clinical experience demonstrates longterm clinically effective closure of the ASDs treated with the ...

ByatHeart Medical


ELIXIR MEDICAL ANNOUNCES OUTSTANDING 24-MONTH DATA FOR DYNAMX CORONARY BIOADAPTOR SYSTEM, DEMONSTRATING STRONG SAFETY WITH NO TARGET LESION REVASCULARIZATION, MYOCARDIAL INFARCTION OR THROMBOSIS THROUGH 24 MONTHS

ELIXIR MEDICAL ANNOUNCES OUTSTANDING 24-MONTH DATA FOR DYNAMX CORONARY BIOADAPTOR SYSTEM, DEMONSTRATING STRONG SAFETY WITH NO TARGET LESION REVASCULARIZATION, MYOCARDIAL INFARCTION OR THROMBOSIS THROUGH 24 MONTHS

The results were presented at the 30th Annual Live Interventions in Vascular Endotherapy conference organized by the National Heart Centre of Singapore (Singapore LIVE). ...

ByElixir Medical Corporation


Robocath successfully carries out Europe’s first remote robotic-assisted coronary angioplasty

Robocath successfully carries out Europe’s first remote robotic-assisted coronary angioplasty

This is essentially because it takes too long to get to an interventional cardiology center (1). This pioneering robotic procedure, the first in Europe carried out at a distance of over 70 miles, could eventually improve patient care in case of serious cardiac events such as heart attacks and strokes, and save lives. ...

ByRobocath


Corindus Announces Global Launch of technIQ™1 Smart Procedural Automation Series for CorPath® GRX System

Corindus Announces Global Launch of technIQ™1 Smart Procedural Automation Series for CorPath® GRX System

Jean Fajadet, M.D., the co-director of interventional cardiology at Clinique Pasteur in Toulouse, France, performed the first in-human coronary procedures with the benefit of the new automated movements, which replicate manual techniques of highly skilled interventionalists. ...

BySiemens Healthcare GmbH

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT